Nomura Holdings’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.48M | Sell |
16,000
-20,000
| -56% | -$4.44M | 0.01% | 736 |
|
|
2025
Q4 | $8.23M | Sell |
36,000
-7,100
| -16% | -$1.62M | 0.01% | 606 |
|
|
2025
Q3 | $9.98M | Buy |
43,100
+23,100
| +116% | +$4.7M | 0.02% | 536 |
|
|
2025
Q2 | $3.71M | Sell |
20,000
-40,000
| -67% | -$7.43M | 0.01% | 660 |
|
|
2025
Q1 | $12.6M | Buy |
60,000
+9,500
| +19% | +$1.85M | 0.02% | 414 |
|
|
2024
Q4 | $8.97M | Buy |
50,500
+17,800
| +54% | +$3.27M | 0.01% | 537 |
|
|
2024
Q3 | $6.46M | Buy |
32,700
+15,000
| +85% | +$2.8M | 0.01% | 568 |
|
|
2024
Q2 | $3.04M | Buy |
17,700
+2,700
| +18% | +$447K | 0.01% | 819 |
|
|
2024
Q1 | $2.73M | Buy |
+15,000
| New | +$2.59M | 0.01% | 820 |
|
|
2023
Q2 | – | Sell |
-79,500
| Closed | -$12.7M | – | 1329 |
|
|
2023
Q1 | $12.7M | Buy |
79,500
+25,800
| +48% | +$3.94M | 0.04% | 299 |
|
|
2022
Q4 | $8.68M | Sell |
53,700
-96,300
| -64% | -$14.8M | 0.04% | 346 |
|
|
2022
Q3 | $20.2M | Sell |
150,000
-100,000
| -40% | -$14.3M | 0.08% | 185 |
|
|
2022
Q2 | $38.4M | Buy |
+250,000
| New | +$38.2M | 0.13% | 100 |
|
|
2022
Q1 | – | Sell |
-3,677,200
| Closed | -$498M | – | 1929 |
|
|
2021
Q4 | $498M | Buy |
3,677,200
+3,297,200
| +868% | +$389M | 1.26% | 14 |
|
|
2021
Q3 | $41.4M | Buy |
+380,000
| New | +$43.4M | 0.1% | 126 |
|
|
2020
Q2 | – | Sell |
-30,000
| Closed | -$2.29M | – | 1094 |
|
|
2020
Q1 | $2.29M | Sell |
30,000
-24,000
| -44% | -$2.04M | 0.01% | 441 |
|
|
2019
Q4 | $4.78M | Sell |
54,000
-26,000
| -33% | -$2.16M | 0.02% | 457 |
|
|
2019
Q3 | $5.86M | Buy |
+80,000
| New | +$5.48M | 0.02% | 427 |
|
|
2018
Q2 | – | Sell |
-413,200
| Closed | -$39.1K | – | 1238 |
|
|
2018
Q1 | $39.1K | Buy |
413,200
+298,200
| +259% | +$32.8M | 0.07% | 155 |
|
|
2017
Q4 | $13M | Buy |
115,000
+48,500
| +73% | +$4.57M | 0.02% | 394 |
|
|
2017
Q3 | $5.91M | Buy |
+66,500
| New | +$5.06M | 0.01% | 499 |
|
|
2017
Q1 | – | Sell |
-9,000
| Closed | -$564K | – | 1246 |
|
|
2016
Q4 | $564K | Sell |
9,000
-10,000
| -53% | -$610K | ﹤0.01% | 1213 |
|
|
2016
Q3 | $1.2M | Buy |
19,000
+9,000
| +90% | +$583K | ﹤0.01% | 751 |
|
|
2016
Q2 | $617K | Buy |
+10,000
| New | +$609K | ﹤0.01% | 830 |
|
|
2015
Q4 | – | Sell |
-40,000
| Closed | -$2.19M | – | 1823 |
|
|
2015
Q3 | $2.19M | Buy |
+40,000
| New | +$2.6M | 0.01% | 571 |
|
|
2015
Q1 | – | Sell |
-142,100
| Closed | -$9.19M | – | 1694 |
|
|
2014
Q4 | $9.19M | Sell |
142,100
-54,400
| -28% | -$3.43M | 0.02% | 379 |
|
|
2014
Q3 | $11.3M | Buy |
196,500
+147,500
| +301% | +$8.19M | 0.03% | 395 |
|
|
2014
Q2 | $2.76M | Buy |
49,000
+9,500
| +24% | +$498K | ﹤0.01% | 979 |
|
|
2014
Q1 | $2.03M | Buy |
+39,500
| New | +$2M | ﹤0.01% | 1174 |
|
Other funds holding ABBV
VCM
VPM
Nomura Holdings's ABBV Position: Q1 2026 in Review
Nomura Holdings reduced its AbbVie (ABBV) stake by 68% in Q1 2026, selling an estimated $5.45M and leaving 11,792 shares worth $2.56M. The position accounts for 0.01% of the portfolio, ranked #845.
Nomura Holdings first reported a position in ABBV in Q2 2013 and has held it in 48 quarters since. The position peaked at $115M in Q3 2019. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Nomura Holdings held 11,792 shares of AbbVie worth $2.56M as of Q1 2026.
- Nomura Holdings sold 24,575 AbbVie shares in Q1 2026, an estimated $5.45M.
- AbbVie made up 0.01% of Nomura Holdings's portfolio in Q1 2026, its #845 holding.
- Nomura Holdings first reported a position in AbbVie in Q2 2013 and has held it in 48 quarters since.
- Nomura Holdings's AbbVie position peaked at $115M in Q3 2019.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.